ArticleOncotarget2017

Safety and tolerability of deferasirox in pediatric hematopoietic stem cell transplant recipients: one facility's five years' experience of chelation treatment.

Natalia Maximova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.